Advanced search
Publication Cover
Journal of Chemotherapy Volume 25, 2013 - Issue 4
Submit an article Journal homepage
69
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns

Chris KosmidisInfectious Diseases and Antimicrobial Chemotherapy Research Laboratory First Department of Propaedeutic Medicine, University of Athens, Greece and 87 Amaroussiou-Chalandriou St, 15233 Chalandri. Email: [email protected]
,
Maria GiannopoulouInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
,
Anastasia FlountziInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
,
Antonis MarkogiannakisInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
,
Dimitris GoukosInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
,
George PetrikkosInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
,
George L DaikosInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
&
Konstantina TzanetouInfectious Diseases and Antimicrobial Chemotherapy Research LaboratoryFirst Department of Propaedeutic Medicine, University of Athens, Greece
 show all
Pages 217-221 | Published online: 05 Nov 2013

References

  • VakulenkoSBMobasheryS. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003;16(3):430–50.
  • MillerGHSabatelliFJHareRSGlupczynskiYMackeyPShlaesD. The most frequent aminoglycoside resistance mechanisms–changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis. 1997;24 Suppl 1:S46–62.
  • MillerGHSabatelliFJNaplesLHareRSShawKJ. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin — a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. J Chemother. 1995;7 Suppl 2:31–44.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100-S22, 2012, CLSI, Wayne, PA, USA.
  • DaikosGLKosmidisCTassiosPTPetrikkosGVasilakopoulouAPsychogiouM. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob Agents Chemother. 2007;51(7):2366–72.
  • GerdingDNLarsonTAHughesRAWeilerMShanholtzerCPetersonLR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother. 1991;35(7):1284–90.
  • GerdingDN. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol. 2000;21(1 Suppl):S12–7.
  • FranceticIKalenicSHuicMMercepIMakar-AuspergerKLikicR. Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study. Croat Med J. 2008;49(2):207–14.
  • PsichogiouMTassiosPTAvlamisAStefanouIKosmidisCPlatsoukaE. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother. 2008;61(1):59–63.
  • ZagorianouASianouEIosifidisEDimouVProtonotariouEMiyakisS. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004–2010. Euro Surveill. 2012;17(7).
  • KontopoulouKProtonotariouEVasilakosKKritiMKoteliAAntoniadouE. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J Hosp Infect. 2010;76(1):70–3.
  • SouliMGalaniIAntoniadouAPapadomichelakisEPoulakouGPanageaT. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364–73.
  • GalaniIXirouchakiEKanellakopoulouKPetrikkosGGiamarellouH. Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin Microbiol Infect. 2002;8(9):579–88.
  • HujerKMHujerAMHultenEABajaksouzianSAdamsJMDonskeyCJ. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50(12):4114–23.
  • Garza-RamosUMorfin-OteroRSaderHSJonesRNHernandezERodriguez-NoriegaE. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother. 2008;52(8):2943–6.
  • SandvangDAarestrupFM. Characterization of aminoglycoside resistance genes and class 1 integrons in porcine and bovine gentamicin-resistant Escherichia coli. Microb Drug Resist. 2000;6(1):19–27.
  • SundeMNorstromM. The genetic background for streptomycin resistance in Escherichia coli influences the distribution of MICs. J Antimicrob Chemother. 2005;56(1):87–90.
  • GebreyesWAThakurS. Multidrug-resistant Salmonella enterica serovar Muenchen from pigs and humans and potential interserovar transfer of antimicrobial resistance. Antimicrob Agents Chemother. 2005;49(2):503–11.
  • GalimandMCourvalinPLambertT. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother. 2003;47(8):2565–71.
  • YanJJWuJJKoWCTsaiSHChuangCLWuHM. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother. 2004;54(6):1007–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.